Showing results (181-190 of 216) with videos related to
Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2016
Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T CellsSylvie Grégoire, Céline Terrada, Gaelle H Martin, et al.Elife|March 30, 2023
Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigensValentin Quiniou, Pierre Barennes, Vanessa Mhanna, et al.Diabetologia|July 2, 2020
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding studyMichelle Rosenzwajg, Randa Salet, Roberta Lorenzon, et al.AIDS (London, England)|June 22, 2022
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2Valérie Pourcher, Lisa Belin, Cathia Soulie, et al.Gastroenterology|March 10, 2017
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia VasculitisCloé Comarmond, Marlène Garrido, Stanislas Pol, et al.Translational Psychiatry|January 11, 2022
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?Dominique Endres, Thomas A Pollak, Karl Bechter, et al.Nature Biotechnology|September 8, 2020
Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biasesPierre Barennes, Valentin Quiniou, Mikhail Shugay, et al.Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.Circulation Research|July 12, 2023
CTLA-4 Pathway Is Instrumental in Giant Cell ArteritisPaul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, et al.Scientific Reports|April 15, 2020
Immunomodulatory role of Interleukin-33 in large vessel vasculitisAnne-Claire Desbois, Patrice Cacoub, Aurélie S Leroyer, et al.Pageof 22